IL-31Rα Polyclonal Antibody

    • Catalog No.:YT5091
    • Applications:WB;ELISA
    • Reactivity:Human;Rat;Mouse;
      • Target:
      • IL-31Rα
      • Fields:
      • >>Cytokine-cytokine receptor interaction
      • Gene Name:
      • IL31RA
      • Protein Name:
      • Interleukin-31 receptor subunit alpha
      • Human Swiss Prot No:
      • Q8NI17
      • Mouse Swiss Prot No:
      • Q8K5B1
      • Immunogen:
      • Synthesized peptide derived from the Internal region of human IL-31Rα.
      • Specificity:
      • IL-31Rα Polyclonal Antibody detects endogenous levels of IL-31Rα protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Polyclonal, Rabbit,IgG
      • Dilution:
      • WB 1:500 - 1:2000. ELISA: 1:40000. Not yet tested in other applications.
      • Purification:
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • Concentration:
      • 1 mg/ml
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • IL31RA;CRL3;GPL;Interleukin-31 receptor subunit alpha;IL-31 receptor subunit alpha;IL-31R subunit alpha;IL-31R-alpha;IL-31RA;Cytokine receptor-like 3;GLM-R;hGLM-R;Gp130-like monocyte receptor;Gp130-like receptor;ZcytoR17
      • Observed Band(KD):
      • 82kD
      • Background:
      • The protein encoded by this gene belongs to the type I cytokine receptor family. This receptor, with homology to gp130, is expressed on monocytes, and is involved in IL-31 signaling via activation of STAT-3 and STAT-5. It functions either as a monomer, or as part of a receptor complex with oncostatin M receptor (OSMR). Several alternatively spliced transcript variants encoding different isoforms have been noted for this gene.[provided by RefSeq, Jun 2011],
      • Function:
      • function:Associates with OSMR to form the interleukin-31 receptor which activates STAT3 and to a lower extent STAT1 and STAT5. May function in skin immunity.,induction:Up-regulated in lesional keratinocytes of patients with atopic dermatitis. Up-regulated by IFNG and lipopolysaccharides.,PTM:N-glycosylated.,similarity:Belongs to the type I cytokine receptor family. Type 2 subfamily.,similarity:Contains 5 fibronectin type-III domains.,subunit:Heterodimer with OSMR. Interacts with JAK1 and STAT3.,tissue specificity:Expressed at low levels in testis, ovary, brain, prostate, placenta, thymus, bone marrow, trachea and skin. Detected in all of the myelomonocytic lineage. Expressed in CD14-and CD56-positive blood cells and by macrophages (at protein level).,
      • Subcellular Location:
      • Cell membrane ; Single-pass type I membrane protein . Cell junction, synapse, presynaptic cell membrane . Cell projection, axon .
      • Expression:
      • Expressed in CD14- and CD56-positive blood cells (PubMed:11877449). Expressed in macrophages (PubMed:16461143, PubMed:18439099). Expressed in keratinocytes (PubMed:21261663). Expressed in a subset of dorsal root ganglia neurons (at protein level) (PubMed:24373353). Expressed at low levels in testis, ovary, brain, prostate, placenta, thymus, bone marrow, trachea and skin (PubMed:15184896, PubMed:11877449, PubMed:14504285). Expressed in bronchial and alveolar epithelial cells and pulmonary fibroblasts (PubMed:18439099). Detected in all of the myelomonocytic lineage (PubMed:14504285). Isoform 6: Expressed at higher levels in lesional skin compared to healthy skin of atopic dermatitis patients (PubMed:24373353).
      • Products Images
      • Western Blot analysis of extracts from Jurkat cells, using IL-31R Polyclonal Antibody. Secondary antibody(catalog#:RS0002) was diluted at 1:20000